202 1 A N N UA L REPORT
Opening Doors To New Horizons
SVS FOUNDATION BOARD OF DIRECTORS
What a year! We struggled with the pandemic and its effects; however, we were able to gather together at the Vascular Annual Meeting once more. And the important work of the SVS Foundation took some big steps forward, thanks to both the support and innovative ideas of our members.
YOU are the key to the SVS Foundation
CORE MISSION OF THE SVS F O U N D AT I O N To optimize the vascular health and well-being of patients and the public through support of research that leads to discovery of knowledge and innovative strategies, as well as education and programs, to prevent and treat circulatory disease.
I particularly want to offer a big thanks to Drs. Peter Nelson and Thomas Forbes for their hard work on the SVS Foundation Development Committee. The old saying— and one of my favorites—is “no money, no mission.” Over this past fiscal year, the SVS Foundation increased its member donations from 17 to 26 percent of SVS members, including contributions from 75 percent of past awardees. The endowment also survived the pandemic and is in good shape, although we always can use more endowment for our many new projects. We launched a new initiative, VISTA—Vascular Volunteers In Service to All (with the moniker “lend a hand to save a limb”)—to address the significant disparities in access to vascular health care across the United States. Social scientists know that a person’s ZIP code is a better predictor of health than his or her genetic code. VISTA is a way to try to even the scales and put some much-needed balance into vascular health care. The program is led by Jens Jorgensen, MD, who proposed it to the SVS and Foundation several years ago. Fortunately, the Foundation had already funded several pilot programs on limb ischemia in underserved communities, so those pilot programs have become the initial VISTA programs. The Foundation will provide outreach and screening, starting with our first pilot project in Oklahoma, which has one of the largest populations of underserved Native American Chronic Limb-Threatening Ischemia patients in the country. We also are taking a look at all of our grants, awards and programs, to assess their success and continued relevance, and we’re investigating new programs as well. Perhaps an idea or two now percolating below the surface will eventually help unlock the keys to vascular disease in the future. The work we fund yields an impressive return on investment. As reported at VAM and in these pages, the Foundation K Awards Program is highly effective in developing vascular surgeon-scientists, with a nearly 9.5-fold return on investment. Despite those impressive results, retention of awardees in research is an important new focus of the Foundation. Remember that YOU are the key to the SVS Foundation. Your participation is key, as well as the amount you give. We will not be satisfied until 100 percent of our members contribute! Please visit vascular.org/svsfoundation to learn more about our mission, programs and funds. Find something you’re interested in and donate today. The future of our specialty and the vascular health of our society is counting on it. Yours truly,
Peter F. Lawrence, MD Chair, SVS Foundation
For 2021-22, SVS Foundation Board of Directors Chair Dr. Peter Lawrence enters the second year of a three-year term. Continuing for an additional one-year term on the board are Drs. Richard Lynn and William Shutze. Dr. Kim Hodgson has transitioned off the board in his role as the SVS immediate past president, as has Dr. Edith Tzeng, former chair of the SVS Research Council. Dr. Raul Guzman joins the board as the new Research Council chair and Dr. Ulka Sachdev-Ost is a new at-large member. Dr. Lawrence thanked Drs. Tzeng and Hodgson for their service to the SVS Foundation. Other members of the SVS Foundation Board of Directors are: SVS President Ali AbuRahma, MD; President-Elect Dr. Michael Dalsing; Immediate Past President Dr. Ronald Dalman; plus Drs. Keith Calligaro; Matthew Eagleton; Joseph Hart and Nasim Hedayati; plus non-surgeon board members Martin Sylvain, MBA; and James Neupert. The addition of non-surgeons to broaden and diversify the board began with the Foundation restructuring in 2020. The SVS Foundation Development Committee is made up of Chair Peter Nelson, MD; Vice Chair Thomas L. Forbes, MD; Lawrence; and Drs. Lisa Bennett; Peter Brant-Zawadzki; Luke Brewster; Rocco Ciocca; Ryan Nolte; Edith Tzeng; and Chandu Vemuri.
21
%
2021 SVS FOUNDATION FISCAL YEAR HIGHLIGHTS
** Liquid Unrestricted Net Assets
26
%
$7,470,372* Total liabilities and equity
of active members (an increase of almost 10% over previous year)
44%
contributions from individual members
64 % 28 %
months of LUNA**— Benchmark 18-24 Months
* Unaudited financial statements; includes cash, investments, and value of pledges for future support
75%
Over
DEAR MEMBERS:
of SVS volunteers contributed
38%
contributions from Foundations/Societies
supporting programs
increase in number of donors over previous year
100
%
of SVS Foundation and SVS Executive Board members are contributors
18%
contributions from corporate supporters
With Foundation help, More Vascular Care Coming to Oklahoma There are new vistas In Oklahoma for those in need of vascular care. That’s “vista” as in Vascular Volunteers In Service To All— VISTA—a new initiative of the SVS Foundation whose mission is “to provide better vascular care to underserved populations in the United States, said Dr. Jens Eldrup-Jorgensen. He conceived of the initiative (see accompanying story) and brought it to the SVS Foundation. He is the medical director for the SVS Patient Safety Organization Vascular Quality Initiative and chairs the VISTA Program Steering Committee. SVS member Kelly Kempe, MD, is overseeing the first VISTA pilot project, “Disparities in Access to Care for Limb Salvage: The Oklahoma Project,” working with the state’s indigenous and rural populations. It builds on current outreach efforts in the state, some of which began as part of Dr. Kempe’s 2020 SVS Foundation Community Awareness and Prevention (CAPP) Grant. Abbot is providing funding for the Oklahoma limb salvage project. Boston Scientific is funding two other pilot projects (see accompanying story).
highest rates of cardiovascular risk factors associated with amputation in the country. The survey also asked PCPs if they were interested in one-on-one conversations to further elucidate the same questions. “We’re identifying the beginning point. What do PCPs see as primary barriers to specific care that leads to major amputation?” said Dr. Kempe. “Why do our patients end up with severe chronic disease and with limb loss?” Though the survey and qualitative data are currently being analyzed, PCPs told Dr. Kempe and her colleagues they would welcome educational resources and awareness. When VISTA came up, “It made sense to utilize the community outreach data we have and keep building in our state, collaborating with a handful of primary care practices.” First up is to get a sense of the obstacles PCPs face, said Dr. Kempe. VISTA volunteers will meet with the practices, distribute educational materials, discuss prevention that will include important physical exam signs, and provide tools such as portable doppler ultrasound equipment to check
VISTA Addressing Needs in Underserved Areas VISTA was born out of Dr. Jens Jorgensen’s desire to reach out and do more. He said he’s always been a bit envious of colleagues who have gone overseas to do medical missionary work, he said in an appearance on the Audible Bleeding podcast, a publication of the Society for Vascular Surgery. With the emphasis emerging over the past year on inequities within the United States and the needs in this country, he brought a concept to bring modern vascular care to underserved communities to the Society for Vascular Surgery Foundation. Refinements and revisions followed, with input from the American College of Surgeons, which has its own charitable programs, to create VISTA—Vascular Volunteers In Service To All. VISTA’s goal is awareness and prevention and its initial project grants support initiatives that emphasize patient education and awareness, as well as risk assessment, and focus on bringing vascular care to areas of need. VISTA organizers reached out to industry and corporate partners. “We were able to bring the VISTA idea to industry and say, ‘We have a project that addresses social disparities. Would you be interested in funding it?’ And actually, we got very quick turnaround on that. “Interestingly, talking to corporations, we found out that their new employees want to know what the companies are doing to address social disparities,” said Dr. Jorgensen. “The folks who are joining these companies want to make sure that the company is also in line with their mission and goals in life. And so there's a really a very strong alignment between VISTA and our corporate partners,” said Dr. Jorgensen. “This is a really a very opportune time for us.” Abbot is funding Dr. Kelly Kempe’s project (see accompanying story); Boston Scientific is providing funding for two additional pilot projects. Joseph Mills of the Baylor College of Medicine is working on “A Patient-Centered Approach to Reduce Diabetes-Related Lower Extremity Amputations among Underrepresented Minorities” and Misty Humphries’ project is “Targeted Outreach in Vascular Deserts to Improve Outcomes for Chronic Limb Threatening Ischemia. Dr. Humphries is with the University of California at Davis.
For both CAPP and this new “disparities” project, Dr. Kempe is working with a multidisciplinary team at the University of Oklahoma. It includes Oklahoma Primary Healthcare Improvement Collaborative (OPHIC), Medical Informatics, Internal Medicine, Podiatry, Vascular Imaging and Dr. Peter Nelson, professor and chief of vascular surgery at University of Oklahoma College of Medicine in Tulsa. Via the CAPP grant, Dr. Kempe surveyed primary care providers (PCPs) throughout the state, asking them to identify barriers to limb salvage in Oklahoma, which has some of the
2
SVS F OU N DATI O N
| 2021 A N N UA L R E P O RT
blood flow. This will help the PCPs become more confident assessing circulation issues and providing more assistance for patients they’re worried about, Dr. Kempe said. The VISTA volunteers want to work to both increase PCPs’ awareness about warning signs and the care vascular surgeons can provide and also to build important and supportive relationships. Then, physicians will know to reach out to vascular surgeons when necessary – and be comfortable doing so, said Dr. Kempe.. ■
Dr. Jorgensen knew of Drs. Peter Nelson and Kempe’s outreach work in Oklahoma, which has one of the highest rates of amputation in the country. Dr. Kempe began her outreach as part of her 2020 SVS Foundation Community Awareness and Prevention (CAPP) Grant. “The patients themselves don't know the seriousness of their situation and they show up very late in the process of their disease. Then we see them eventually in the emergency room, for example, and have very limited options in terms of treatment,” said Dr. Nelson. ■
3
SVS F OU N DATI O N C A REE R DE V ELO PM E NT PROG R A M
Recent study shows a major SVS Foundation research award program brings a 9.5-fold return on investment
SVS F OU N DATI O N RES E A RC H FELLOWS H I P
How mentorship and research paved the way for growth and excellence in the field of vascular surgery
T H E S V S F - C DA P R O G R A M WA S I N I T I AT E D I N 1 9 9 9 TO P R OV I D E S U P P L E M E N TA L F U N D S TO R E C I P I E N T S O F N AT I O N A L
S V S F O U N D AT I O N A W A R D S C A N P AY E N O R M O U S D I V I D E N D S , N O T J U S T I N T E R M S O F R E S E A R C H G A I N S B U T A L S O
I N S T I T U T E S O F H E A LT H ( N I H ) K0 8 / K 2 3 C A R E E R D E V E LO P M E N T G R A N T S . T H E S V S L I F E L I N E F O U N DAT I O N ( N O W T H E S V S
I N I N F L U E N C I N G T H E P R O F E S S I O N ' S F U T U R E . T H E S V S F O U N D AT I O N S T U D E N T R E S E A R C H F E L L O W S H I P S T I M U L AT E S
F O U N DAT I O N ) F O U N D E D T H E P R O G R A M I N PA R T N E R S H I P W I T H T H E N I H ’ S N AT I O N A L H E A R T, LU N G , A N D B LO O D I N S T I T U T E
L A B O R ATO R Y A N D C L I N I C A L VA S C U L A R R E S E A R C H B Y U N D E R G R A D UAT E C O L L E G E S T U D E N T S A N D M E D I C A L S C H O O L
( N H L B I ) . B OT H E N T I T I E S R E C O G N I Z E T H E I M P O R TA N C E O F S C I E N T I F I C D I S C OV E R Y TO T H E E VO LU T I O N O F H E A LT H C A R E A N D
S T U D E N T S R E G I S T E R E D AT U N I V E R S I T I E S I N T H E U N I T E D S TAT E S A N D C A N A DA . T H E I N T E N T I S TO F U R T H E R T H E S T U D E N T S ’
T H E E S S E N T I A L R O L E T H AT VA S C U L A R S U R G E O N - S C I E N T I S T S P L AY I N T H AT P R O C E S S . T H E Y R E C O G N I Z E T H E N E E D TO G R O W T H E P I P E L I N E O F VA S C U L A R S U R G E O N - S C I E N T I S T S A N D S U S TA I N T H E M T H R O U G H O U T T H E I R C A R E E R S .
Since its inception, the SVSF has committed $12 million to 34 vascular surgeon-scientists who have completed their K award funding, and seven who are currently being supported. The study authors analyzed the outcomes for the 41 recipients of the SVSF supplemental funding to determine the programmatic accomplishments, the return on investment, and areas for strategic improvement. Financial ROI for the SVSF-CDA was defined as federal research dollars divided by the total financial commitment by the SVSF-CDAs to the awardees. The study concluded that the SVSF-CDA Program is highly effective in developing vascular surgeon-scientists who contribute to the leadership and growth of academic
Demographic Highlights:
vascular surgery. Program recipients have secured $114 million in federal funding, a 9.5-fold financial ROI for the SVSF. The study did reveal areas for ongoing strategic improvement. The number of female vascular surgeon-scientists and award recipients has greatly increased in the last 10 years but the lack of racial and ethnic diversity is strikingly notable. A goal will be to enhance the diversity of our pipeline of future vascular surgeon-scientists. A second finding is that only 44% remain funded over time and emphasizes the essential need to retain these successful individuals in research in order to support the growth of the pipeline and continue to drive scientific discovery in vascular disease. ■ Read more about this study here: vascular.org/ResearchROI
Trends amongst the 41 recipients:
Recipient Updates of Note:
• Recipients: 73% male and 27% female with 75% of current awardees being female; 4.5% Hispanic and 2.4 Black.
• Prior to residency research training, 46% received NIHsupported training or Howard Hughes Research Fellowships
• 62% successfully obtained NIH R01, VA or Department of Defense funding
• Median age across the 22-year interval: 40
• 51% obtained additional degrees beyond their MDs
• Thirty-two U.S. academic institutions represented
• 76% received early-career funding from societal, nonprofit foundations, VA or AHA sources
• 46% secured tenure at their institutions
• At the time of funding, 85% assistant professors, and 13% associate professors.
• 27% hold endowed professorships
• 44% have served as division chiefs, 27% as program directors, 12% as chairs of Departments of Surgery and 2% as deans • 27% have served as president of a regional or national society • 59% participate in NIH study sections • 44% maintain active independent research funding
JVS Article Title: Fostering the Vascular Surgeon-Scientist: A 20-Year Analysis of the Society for Vascular Surgery Foundation Mentored Research Career Development Award,” outlines the positive effects of the SVS Foundation Career Development Program (SVSF-CDA). It was presented in August at the 2021 Vascular Annual Meeting in San Diego. 4
SVS F OU N DATI O N
| 2021 A N N UA L R E P O RT
E D U C AT I O N A N D I N T R O D U C E T H E M TO A P P LY I N G R I G O R O U S S C I E N T I F I C M E T H O D S TO C L I N I C A L P R O B L E M S A N D U N D E R LY I N G B I O LO G I C P R O C E S S E S S I G N I F I C A N T TO PAT I E N T S W I T H VA S C U L A R D I S E A S E .
Dr. Nicholai Henry was a third-year medical student when he received the Student Research Fellowship Award in 2017. During his time in medical school at Morehouse School of Medicine, Dr. Luke Brewster was his SVS Member Mentor. They discuss the impact of the award.
“
The SVS Foundation Student Research Fellowship is a prestigious award recognizing promising medical students and cutting-edge research under the direction of a vascular surgeon-scientist or clinical investigator. Some of our SVS' best and brightest mentors participate, and the competition for these awards is excellent. This award provides students with a stipend for their effort. In addition, the award introduces students to the vascular surgery group at their institution and vascular surgeons from around the country through research presentations and attendance at the Vascular Annual Meeting.
”
I was very privileged to have met Dr. Henry when he was in medical school. His interest in vascular and vascular science spurred us to put together our proposal and likely helped Dr. Henry match into a vascular residency. To my knowledge, Dr. Henry is the first Morehouse School of Medicine graduate to match into integrated vascular residency. Great job, Dr. Henry!
“
Luke Brewster, MD, PhD Emory University, Atlanta, Ga
"I had the honor of working alongside Dr. Brewster during my SVS Fellowship. The SVS Student Research Fellowship afforded me a platform to expand upon my interest in the etiopathology of peripheral artery disease progression. In addition, it provided mentorship and sponsorship opportunities that advanced my career towards academic surgery and laid a unique foundation for contributing to evidence-based medicine."
Nicholai Henry, MD Albany Medical Center, Albany, NY Student Research Fellowship Awardee
” 5
Clinical Research Seed Grant
IN PAYING BACK, JOE HART PAYS IT FORWARD For Joe Hart, a larger donation to the SVS Foundation this past year is helping him pay back several of his own scholarships and research opportunities from which he benefited. “I’m someone who’s been fortunate to get scholarships,” he said of his undergrad and medical school years. “I’m from a big family— I needed the help! So I try to pay things back where I can. I’ve always been involved, but I was able to do something more substantial this year.”
Joe Hart, MD
“I know it’s difficult to get funding, I know it’s important. Grants help our people get more funding to keep up their research, without clinical practice getting in the way.”
During medical school at Northwestern, he received funding for a research opportunity he feels helped him get started in the right direction. After fellowship he won an award in the Marco Polo Program to go to Europe for six months for training, research and project work. Now he tries to impact the future of vascular patient care by helping fund research that will affect that care. He calls himself a “hybrid,” working primarily in a clinical practice but also still trying to keep his hand in when it comes to research. He spent six years trying to make it his full-time pursuit. But funding was an issue as were the difficulties—as many researchers know—balancing research, clinical and patient needs.
Contributions to the SVS Foundation help researchers get that precious time they need to pursue projects to improve patient care, he said. “I know it’s difficult to get funding, I know it’s important. Grants help our people get more funding to keep up their research, without clinical practice getting in the way.” Dr. Hart also gives his time, serving on both the SVS Foundation Board of Directors and the VISTA—Vascular Volunteers In Service To All—Steering Committee. And after spending more than five years in a relatively rural setting in northern Maine, he also understands and appreciates some of the Foundation’s newer initiatives, such as VISTA—Vascular Volunteers Improving Service to All—aimed at providing access to vascular care to under-served populations. (see story on pages 2-3) He encourages everyone to participate in the Foundation’s work, echoing the sentiments of other Foundation committee members. “Even in my mac and cheese days I gave a little,” he said. “And I’m glad I’m in a place in my life where I can. It seems like the right thing to do.” ■
Foundation Challenges Bring in New Donors T H A N K S TO T H E G E N E R O S I T Y O F F O U R M E M B E R S W H O C H A L L E N G E D M E M B E R S TO G I V E , T H E S V S F O U N DAT I O N R E C E I V E D N E A R LY $1 2 , 0 0 0 I N 2 0 2 0 Y E A R - E N D C O N T R I B U T I O N S F R O M M O R E T H A N 4 0 N E W D O N O R S .
New donors (or those who had not contributed in the past five years or more) contributed $11,878 during the 2020 year-end Matching Gift Challenge, with the four members— Drs. William Shutze, Thomas Forbes, Peter Nelson, and Jens Eldrup-Jorgensen—providing an additional $10,000 in matching funds. Contributions went specifically to the Greatest Need Fund ($9,910 from 37 new donors, an additional $8,000 in matching funds and the Awareness and Prevention Fund for community health initiatives ($2,468, with $2,000 more in matching funds). Dr. Shutze kicked off the matching challenge, hoping to help early- and mid-career surgeons develop the “giving habit.”
6
SVS F OU N DATI O N
| 2021 A N N UA L R E P O RT
He himself is a latecomer as a Foundation donor, becoming more involved when he saw that the Foundation and its projects—including patient education flyers and other community health initiatives—impact all SVS members. “In my early career I didn’t have a lot to give,” Dr. Shutze said. “I thought offering matching funds would be a way for earlyand mid-career surgeons who may not have a lot of philanthropic funds to be more impactful; if they give $100, they’re really giving $200.” Eldrup-Jorgensen reminded members that “many of our corporate sponsors measure our engagement by the percentage of members who contribute. So please contribute. Everything helps.” ■
SVS FOUNDATION ANNOUNCES AWARDS, GRANTS
Katharine L. McGinigle, MD, MPH University of North Carolina Using Precision Medicine to Define Adaptive Treatment Strategies for Patients with Chronic Limb-Threatening Ischemia Cassius Iyad Ochoa Chaar, MD, MS Yale University School of Medicine Genetic Variants Associated with Premature Peripheral Arterial Disease
Resident Research Award SVS Foundation Mentored Patient-Oriented Research Career Development Award (K23); awarded in December 2020 Tze-Woei Tan, MD University of Arizona Determinants in Limb Preservation in Hispanics and Native Americans
W. James Melvin, MD General Surgery Resident University of Michigan Medical Center Coronavirus Induces Diabetic Macrophage-mediated Inflammation via IFNβ Regulation of SETDB2 MENTOR: Katherine Gallagher, MD
VISTA Pilot Project Grants
SVS Foundation and American College of Surgeons Mentored Clinical Scientist Research Career Development Award K08
Misty Humphries, MD University of California Davis Targeted Outreach in Vascular Deserts to Improve Outcomes for Chronic Limb Threatening Ischemia
Andrea T. Obi, MD University of Michigan Medical School Myeloid TLR4 Epigenetic Regulation and Signaling in Accelerating Venous Thrombus Resolution
Kelly Kempe, MD University of Oklahoma School of Community Medicine Disparities in Access to Care for Limb Salvage: The Oklahoma Project
SVS Foundation Mentored Patient-Oriented Research Career Development Award (K23) Caitlin W. Hicks, MD Johns Hopkins University Risk Factors and Outcomes Associated with Late-Life Diabetic Peripheral Neuropathy
E.J. Wylie Traveling Fellowship Shipra Arya, MD Stanford University School of Medicine With vascular patients suffering a high prevalence of geriatric syndromes, Dr. Arya wants to gain a more comprehensive understanding of perioperative optimization and pre-habilitation care models at various centers across the United States and Canada and develop such a center at Stanford Hospital and Clinics.
Joseph Mills, MD Baylor College of Medicine A Patient-Centered Approach to Reduce Diabetes-Related Lower Extremity Amputations among Underrepresented Minorities
Vascular Research Initiatives Conference Trainee Awards Elizabeth Andraska, MD University of Pittsburgh Medical Center Abstract title: Early Upregulation of Elastolysis Allows for Collateral Formation After Arterial Occlusion MENTOR: Ryan McEnaney, MD Luis Gonzalez, BS Yale University School of Medicine ABSTRACT TITLE: Role of Tenascin-C in Venous Remodeling Following AVF Creation MENTOR: Alan Dardik, MD
Margaret Nalugo, MD, PhD Washington University School of Medicine in St. Louis ABSTRACT TITLE: Towards A Cure for Diabetes: Pancreatic Tissue Encapsulation and Implantation In A Novel Arteriovenous Graft MENTOR: Mohamed Zayed, MD Sriganesh Sharma, MD, PhD University of Michigan ABSTRACT TITLE: Induction of the Epigenetic Enzyme KMT2A/MLL1 and Urokinase in Macrophages After Murine Coronavirus Infection Contributes to Hyperfibrinolysis MENTOR: Andrea Obi, MD
Student Research Fellowship Awards John Miller Allan University of Alabama at Birmingham, School of Medicine PROJECT TITLE: Impact of Post-operative Smoking Cessation on Long Term Outcomes in Patients Undergoing Treatment for Intermittent Claudication SPONSOR: Emily Spangler, MD, MS Adam Michael Brown Medical University of South Carolina PROJECT TITLE: Tension-induced Signaling Through the Serum and Glucocorticoidinducible Kinase-1 (SGK-1) Drives Interleukin-6 (IL-6) Expression in Aortic Vascular Smooth Muscle cells (VSMCs) SPONSOR: Jean Marie Ruddy, MD Nina Byskosh Northwestern Feinberg School of Medicine PROJECT TITLE: Improving PAD Knowledge and Patient Empowerment with a Focused Education Intervention in a Vascular Surgery Cohort SPONSOR: Karen J. Ho, MD Hanu Chaudhari Western University PROJECT TITLE: Feasibility Study of a Handheld Ultrasound and Needle Guide Device for Training Diverse Providers to Perform Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in a Clinical Simulation Program SPONSOR: Adam Power, MD Yancheng Dai University of Pittsburgh, School of Medicine/UPMC PROJECT TITLE: Natural History of Abdominal Aortic Aneurysm Sac Regression After Elective EVAR SPONSOR: Nathan L. Liang, MD
7
Marlene I. Garcia-Neuer Ohio State University Wexner Medical Center PROJECT TITLE: Retrospective Administrative-Claims Data Analysis of Medical Management of Type B Aortic Dissections SPONSOR: Mounir J. Haurani, MD Kenneth Clayton Harland University of Florida and Malcolm Randall VA PROJECT TITLE: Role of Electronic Cigarette Smoke-induced Skeletal Muscle Atrophy in Limb Ischemia SPONSOR: Salvatore Scali, MD Kameel Khabaz University of Chicago PROJECT TITLE: Using Machine Learning to Predict Post-TEVAR Complication Risk from Aortic Shape SPONSOR: Ross Milner, MD Sydney Olson University of Wisconsin School of Medicine and Public Health PROJECT TITLE: Relationship of Iliac Anatomy to Adverse Events in Iliac Branch Devices: Standardized Analysis of CT Imaging SPONSOR: Jon Matsumura, MD Keyuree Kirtikumar Satam Yale School of Medicine PROJECT TITLE: Do Sex Hormones Explain Sex Differences During Arteriovenous Fistula Maturation? SPONSOR: Alan Dardik, MD, PhD Matthew Tiojanco University of Nebraska Medical Center PROJECT TITLE: Effects of Plasma Blood Glucose, Hemoglobin 1A Glycosylation (HGB1A), and Plasminogen Activator Inhibitor 1A (PAI1A) on AAA Growth Rate SPONSOR: B. Timothy Baxter, MD
SVS Foundation Award Opportunities SVS FOUNDATION AWARD
Mentored Research Career Development Awards Program Resident Research Award
VRIC Trainee Award
Student Research Fellowship
Clinical Research Seed Grant
E.J. Wylie Traveling Fellowship
APPLICATION DEADLINE
LEGACY PROGR AM DONORS
| 2021 A N N UA L R E P O RT
SVS Foundation during their lifetimes. They are honored in perpetuity for their commitment to the specialty.
Winter 2022 (VAM abstract deadline)
Winter 2022 (VAM abstract deadline)
February 1, 2022
March 1, 2022
March 1, 2022
For more information on all SVS Foundation awards and programs, visit vascular.org/FoundationAwards.
The Legacy Program is grateful to every category of donor in this program:
Founder’s Circle
Director’s Circle
Benefactor’s Circle ($10,000 - $24,999)
American College of Surgeons
George Andros, MD
Anonymous Donor
Arthur I. Auer, MD
Joan L. and Julius H. Jacobson II
Richard P. Cambria, MD
Director’s Circle ($25,000-$49,999) President’s Circle ($50,000-$99,999) Chairman’s Circle ($100,000 - $499,999) Founder’s Circle ($500,000+) These contributors are leaders who best understand our specialty’s critical need for innovative researchers and the need to provide patient education for prevention of circulatory disease.
($500,000–plus)
William J. von Liebig Foundation
Chairman’s Circle ($100,000–$499,999)
Edwards Vascular Foundation James DeBord, MD
($25,000–$49,999)
Alexander W. Clowes, MD†
Michael C. Dalsing, MD Susan Detweiler, MD
Division of Vascular and Endovascular Surgery, Massachusetts General Hospital Eastern Vascular Society Nicholas D. Garcia, MD
Peter and Karen Lawrence
Vivienne J. Halpern, MD
President’s Circle
New England Society for Vascular Surgery
($50,000–$99,999)
C. Keith Ozaki, MD
Midwestern Vascular Surgical Society Society for Clinical Vascular Surgery Western Vascular Society
Southern Association for Vascular Surgery
William H. Pearce, MD
Daniel B. Walsh, MD and Teri Walsh, RN
Benefactor’s Circle (10,000–$24,999)
† Indicates deceased
SVS F OU N DATI O N
who have contributed a total of $10,000 or more to the
NIH K Award deadlines
* If you note any omissions or corrections, please contact Allison Kohlbrenner at SVSFoundation@ vascularsociety.org or 312-334-2352. Early contributions to the Lifeline Foundation or the American Vascular Association® may not be reflected.
8
The SVS Foundation's Legacy Program includes those
John Abele Ali AbuRahma, MD K. Ramesh Adiga, MD Samuel S. Ahn, MD Donald L. Akers, MD Dennis F. Bandyk, MD Robert C. Batson, MD B. Timothy Baxter, MD John J. Bergan, MD† Victor M. Bernhard, MD Paul S. Brown Jr., MD Allan D. Callow, MD† Joseph E. Carney, MD G. Patrick Clagett, MD
Jon R. Cohen, MD E. Stanley Crawford, MD† Jack L. Cronenwett, MD Ronald L. Dalman, MD Herbert Dardik, MD† R. Clement Darling III, MD Mark G. Davies, MD, PhD David Deakins, MD Michael E. DeBakey, MD† Dominic A. DeLaurentis, MD† Ralph G. DePalma, MD James A. DeWeese, MD† R. Howard Dobbs, MD
Magruder C. Donaldson, MD William H. Edwards, MD Calvin B. Ernst, MD† Ronald M. Fairman, MD Rumi Faizer, MD William R. Flinn, MD Thomas L. Forbes, MD Julie Ann Freischlag, MD Bruce L. Gewertz, MD Gary Giangloa, MD Peter Gloviczki, MD John F. Golan, MD Richard M. Green, MD 9
Benefactor’s Circle, continued
Lazar J. Greenfield, MD Thomas J. Greenfield, MD Roger T. Gregory, MD John W. Hallett, Jr, MD Joseph P. Hart, MD, MHL, FACS Norman R. Hertzer, MD Robert W. Hobson II, MD† Glenn C. Hunter, MD Anthony M. Imparato, MD Bengt L. Ivarsson, MD George Johnson Jr., MD† William D. Jordan Jr., MD Robert L. Kistner, MD Larry W. Kraiss, MD Marvin E. Kuehner, MD Robert P. Leather, MD† Stephen E. Lee, MD Frank W. LoGerfo, MD Joseph G. Magnant, MD Michel S. Makaroun, MD William T. Maloney, MD John A. Mannick, MD Rebecca Maron, CAE Kenneth E. McIntyre Jr, MD Joseph L. Mills Sr, MD R. Scott Mitchell, MD Gregory L. Moneta, MD Wesley S. Moore, MD Robert W. Oblath, MD John L. Ochsner, MD† Kenneth and Joy Ouriel Malcolm Perry, MD† John J. Ricotta, MD Thomas S. Riles, MD Gary R. Seabrook, MD Pathanjali P.V. Sharma, MD Alexander D. Shepard, MD Gregorio A. Sicard, MD Robert B. Smith III, MD Ronald J. Stoney, MD David S. Sumner, MD† George T. Sugiyama, MD Vascular & Endovascular Surgery Society Frank J. Veith, MD Fred Weaver, MD Jock R. Wheeler, MD Anthony D. Whittemore, MD Samuel J. Williams, MD James S. T. Yao, MD, PhD Robert M. Zwolak, MD, PhD
10
SVS F OU N DATI O N
These organizations contributed to the
ORGANIZATION DONORS
SVS Foundation between April 1, 2020, and March 31, 2021.
SOCIETY CONTRIBUTORS
FOUNDATION CONTRIBUTORS
American College of Surgeons
Edwards Vascular Foundation
SURGERY DEPARTMENT CONTRIBUTORS
University of Massachusetts Medical Center, Division of Vascular and Endovascular Surgery
The Mote Vascular Foundation, Inc. CORPORATE CONTRIBUTORS
Abbott Labs Gore & Associates Medtronic Salesforce.com, Inc.
The SVS Foundation thanks and appreciates INDIVIDUAL DONORS
all who contribute. The following includes individuals and Donor Advised Funds who made contributions to the SVS Foundation between April 1, 2020 ,and March 31, 2021.
GREATEST NEED (Annual Fund)
Oliver O. Aalami, MD Shahram Aarabi, MD, MPH Babak Abai, MD Ahmed M. Abou-Zamzam, Jr., MD Cherrie Abraham, MD Christopher J. Abularrage, MD Ali F. AbuRahma, MD John G. Adams Jr., MD, MBA, FACS, FSVS Eric Adams, MD Riad Adoumie, MD Rana Afifi, MD Christopher J. Agrusa, MD Francesco A. Aiello, MD, MBA
| 2021 A N N UA L R E P O RT
Donald L. Akers, MD Hasan A. Aldailami, MD Omar Abdullah Alfarhan, Jr. Babatunde H. Almaroof, MD, FACS Jose Ignacio Almeida, MD Brett A. Almond, MD, PhD Tarek A. Alshafie, MD Daniel M. Alterman, MD, FACS, FSVS, RPVI Kwame S. Amankwah, MD Anoushiravan Amini Hadjibashi, MD Charles A. Andersen, MD Leonard S. Anderson, MD James Nelson Antezana, MD George E. Anton, MD
Herbert D. Aronow & Stefanie P. Aronow Charitable Fund Shipra Arya, MD, SM, FACS Robert G. Atnip, MD Arthur & Marian Auer Philanthropic Fund Bernadette Aulivola, MD Ali Azizzadeh, MD Nobuyoshi Azuma, MD Sateesh C. Babu, MD Martin R. Back, MD Dan J. Badia, MD William H. Baker, MD Nilesh N. Balar, MD, MBA, RVT Zachary K. Baldwin, MD Dennis F. Bandyk, MD
Marcus Barber, MD Donald T. Baril, MD Adel Barkat, MD Peter Bartline, MD Jonathan Bath, MD Bernard Timothy Baxter, MD Todd M. Bayer, MD Hernan A. Bazan, MD, FACS Carlos Bechara, MD Adam W. Beck, MD Brian R. Beeman, MD Michael Belkin, MD William H. Bell III, MD Marshall E. Benjamin, MD Lisa Bennett, MD Scott A. Berceli, MD, PhD Marcos Costa Berenguer, Jr., MD Eric Berens, MD Thomas M. Bergamini, MD Alan Berger, MD Scott S. Berman, MD, MHA Joel A. Berman, MD Thomas R. Bernik, MD, FACS Edwin G. Beven, MD Reva Bhushan Jean Bismuth, MD James H. Black, MD John Blebea, MD, MBA Paul H.S. Bloch, MD, RVT Devon E.M. Bock, MD Suellen Stevam Timotheo Bonadiman, MD Matthew Jacob Borkon, MD Jose Roberto M. Borromeo, MD April J. Boyd, MD, PhD, FRCSC Soma M. Brahmanandam, MD Peter B. Brant-Zawadzki, MD John G. Brawley, MD Mark Joseph Brennan, DO, FACOS, RVT, RPhS, RPVI, RVS Luke Packard Brewster, MD, PhD Joanna Bronson Benjamin S. Brooke, MD, PhD Estela Brooke, MD Thomas E. Brothers, MD O. William Brown, MD, JD Kellie R. Brown, MD Kevin J. Bruen, MD Christopher T. Bunch, MD Jason S. Burgess, MD James A. Burks, Jr., MD Scott D. Burnett, PA Patricia Burton, MS Ruth L. Bush, MD, JD, MPH
Mark W. Byrge, DO Ernesto Caban Rebecca Cabin Phillip L. Cacioppo, MD Keith D. Calligaro, MD William Cuyler Calton, Jr., MD Marcio Wilker Soares Campelo, MD, MSc., PhD Nadine F. Caputo Francis J. Caputo, MD Richard Carballo, MD Douglas Carlon, MD Alfio Carroccio, MD Thomas Nicholas Carruthers, MD, RPVI John G. Carson, MD RPVI FACS Juan M. Castillo, MD Marlin Wayne Causey, MD Rabih A. Chaer, MD Venita Chandra, MD Bill K. Chang, MD Benjamin B. Chang, MD Scotty Chapman, MD Kristofer Charlton-Ouw, MD Anthony Hung Chau, MD David P. Christenberry, MD Jayer Chung, MD Phillip J. Church, MD Rocco G. Ciocca, MD Paul Citrin, MD Daniel G. Clair, MD William Darrin Clouse, MD Salomon Cohen, MD, FACS Dawn M. Coleman, MD Paul S. Collins, MD James Mobley Combs, MD Michael S. Conte, MD Sheila M. Coogan, MD Patrick R. Cook, DO, FACS James Cornwall, MD Michael J. Costanza, MD Bradley Coulter, RVS, RDCS Daniel Cox, MD Brian W. Coyle, MD James E. Craven, MD Paul Crisostomo, MD, RPVI, FACS The Jack and Debra Cronenwett Charitable Fund Leslie D. Cunningham, MD, PhD John A. Curci, MD Michael A. Curi, MD Thomas K. Curry, MD Ronald L. Dalman, MD Michael C. Dalsing, MD Scott Michael Damrauer, MD
Alan Dardik, MD, PhD, DFSVS, FACS R. Clement Darling, III, MD Jeffery Dattilo, MD Luis R. Davila-Santini, MD Rajeev Dayal, MD Luis Fernando Queiroz De Lima, MD Randall Rich DeMartino, MD Richard J. DeMasi, MD Richard Denney, MD Sarasi K. Desikan, MD Maria Alejandra Diaz, MD Alan M. Dietzek, MD Paul DiMusto, MD Karl P. Dittrich, MD Maura Doherty Gregory S. Domer, MD Carlos E. Donayre, MD William Doscher, MD Adam J. Doyle, MD Laura Marie Drudi, MD Anahita Dua, MD Luc Dubois, MD, MSc Joseph Jeremy DuBose, MD Greg Dummer Audra A. Duncan, MD Joseph R. Durham, MD Yazan Duwayri, MD Matthew J. Eagleton, MD Eugene Eddlemon, MD Matthew S. Edwards, MD Mark T. Eginton, MD Jens Eldrup-Jorgensen, MD Sean J. English, MD Young Erben, MD Luke Stephan Erdoes, MD Mark K. Eskandari, MD James M. Estes, MD Jaime Gerardo Estrada, MD Yana Etkin, MD Ronald M. Fairman, MD Rumi Faizer, MD Andres Fajardo, MD Alik Farber, MD Ziad Fayad, MD Robert J. Feezor, MD Antoine M. Ferneini, MD Giovanni A. Ferrante, MD Brian L. Ferris, MD David Feuer, MD Uwe Fischer, MD John J. Flanagan, MD D. Preston Flanigan, MD Thomas L. Forbes, MD Brian Freeman, MD Michael B. Freeman, MD
Carter B. Freiburg, MD Patricia C. Furey, MD Dennis R. Gable, MD Yves A. Gabriel, MD John F. Gallagher, MD Katherine A. Gallagher, MD Manuel Garcia-Toca, MD, MS Nicholas J. Gargiulo III, MD Charles S.C. Garnette, MD Robert M. Gasior, MD Warren J. Gasper, MD Susan Guin Gatten, RN Michael Ellis Gaunt, MD, FRCS Elizabeth Anne Genovese, MD, MS Todd W. Gensler, MD Patrick Geraghty, MD, DFSVS, FACS, RPVI Ted Gifford, MD Julia Glaser, MD Natalia Glebova, MD, PhD, FACS, FSVS Peter Gloviczki, MD James M. Goff, Jr., MD John F. Golan, MD Michael A. Golden, MD Marat Goldenberg, MD Irene Goldstein, MD Michael Gooden, MD Philip P. Goodney, MD James J. Goodreau, MD Alan M. Graham, MD Robert J. Grossi, MD Prem C. Gupta, MD Raul J. Guzman, MD Vincent J. Guzzetta, MD Pantelis Hadjizacharia, MD Ryan T. Hagino, MD Pegge M. Halandras, MD John (Jeb) W. Hallett, MD Kevin D. Halow, MD Vivienne J. Halpern, MD, FACS Omar Hamdallah, MD David C. Han, MD Dinah Hanna, MD, FACS Sachinder S. Hans, MD Jimmy C. Haouilou, MD Shahid N. Haque, MD, FACS Russell N. Harada, MD E. John Harris, MD Linda M. Harris, MD Joseph P. Hart, MD, MHL, FACS Elizabeth Hartmann, MD Ravishankar Hasanadka, MD Paul B. Haser, MD, FACS, FRCSC Homayoun A. Hashemi, MD 11
Direct Dollars to Favorite Fund The SVS Foundation provides donors the opportunity to direct their dollars to specific areas of interest. A contributor could have the zeal to fund the SVS Foundation’s core mission of research, or the new community initiatives, or simply the area of greatest need. The SVS Foundation funds include: GREATEST NEED (Annual Fund)
DISASTER RELIEF FUND
Support SVS Foundation programs when and where needs arise. Your gift to the Foundation will ensure that there will always be resources to support and advance our mission.
Your gift to the Disaster Relief Fund will provide assistance to vascular surgery practices and vascular patients in disaster-devastated communities.
AWARENESS AND PREVENTION (Community Health Initiatives)
ALEXANDER W. CLOWES DISTINGUISHED LECTURE FUND
Your gift will support our expanded mission in disease prevention, patient education and public awareness and community health initiatives. RESEARCH GRANTS
Your gift will support the Foundation’s research awards program for vascular surgeon scientists, clinical researchers, residents and medical students. Support SVS Foundation’s core mission—to fund crucial vascular research that improves patient health.
Mounir J. Haurani, MD Nasim Hedayati, MD, MS Andy Henderson, BA Peter K. Henke, MD Diego A. Hernandez, MD Juan Jose Hernandez Maldonado, MD Richard Hershberger, MD Caitlin Whitney Hicks, MD, MS Anil P. Hingorani, MD Carlos A. Hinojosa, MD Jeffrey C. Hnath, MD John Richard Hobson Jr., MD, FACS Kim J. Hodgson, MD, DFSVS Kakra Hughes, MD, PhD Misty D. Humphries, MD, MAS, RPVI, FACS Jason Richard Hurd, MD Mark D. Iafrati, MD Daniel M. Ihnat, MD Benjamin M. Jackson, MD Akhilesh Kumar Jain, MD, FACS James Jen, MD Jeffrey Jim, MD, MPHS
12
SVS F OU N DATI O N
Robert A. Jimenez, MD Fernando L. Joglar, MD Kaj H. Johansen, MD, PhD, FACS Leka Johnson Adam P. Johnson, MD, MPH Brad L. Johnson, MD Douglas W. Jones, MD Milan Jordan, MD, MPH Dejah R. Judelson, MD Loay S. Kabbani, MD, MHAS Fernando E. Kafie, MD Mark B. Kahn, MD Steven S. Kang, MD Nikhil Kansal, MD Nikolaos Karagiorgos, MD Vikram S. Kashyap, MD Gregory C. Kasper, MD Neelima Katragunta, MD, FACS Gregory J. Kechejian, MD Rebecca Kelso, MD Kelly Kempe, MD Niki Kennedy, MD K. Craig Kent, MD Erika R. Ketteler, MD Muhammad Asad Khan, MD
| 2021 A N N UA L R E P O RT
Support the annual Alexander W. Clowes Distinguished Lecture at the Vascular Research Initiatives Conference and honor the memory of our colleague and internationally recognized vascular surgeon-scientist, Dr. Alexander W. Clowes. To contribute by mail: Please make checks payable to SVS Foundation. Designate the area of interest in the memo field and mail to: SVS Foundation 35312 Eagle Way Chicago, IL 60678-1353
Vipul Khetarpaul, MD Melina R. Kibbe, MD Michael J. Kikta, MD Terry A. King, MD John S. Kirkland, MD, PhD Lee Kirksey, MD Melissa Kirkwood, MD Mark Kissin, MD Dr. Robert L. and Adelaide Kistner Gift Fund Sarah Elizabeth Koch, MD Allison V. Kohlbrenner, MBA Angela A. Kokkosis, MD Issam Koleilat, MD Emilia Król, MD Larry W. Kraiss, MD Timothy F. Kresowik, MD Matthew Kronick, MD Scott Kujath, MD Shameem S. Kunhammed, MD Michael J. Kunstmann, DO Christopher J. Kwolek, MD Chris LaGraize, MD Andrew D. Lambert Gregory J. Landry, MD Robert A. Larson, MD
David L. Lau, MD, FSVS, FACS Lannery S. Lauvao, MD Lawrence Giving Fund Alice Lee, MD Jason T. Lee, MD Cheong J. Lee, MD Stephen E. Lee, MD Steven A. Leers, MD Michael A. Leke, MD Gary W. Lemmon, MD Benjamin M. Lerner, MD Nathan Liang, MD Timothy Liao, MD Jerry Thomas Light, Jr., MD Judith C. Lin, MD, MBA Meryl Simon Logan, MD Shang A. Loh, MD Joann M. Lohr, MD Joyce Lu, MD Sarah Lucas, MD Layla Corral Lucas, MD John F. Lucas III, MD Fedor Lurie, MD, PhD, RPVI, RVT Sean P. Lyden, MD Thomas G. Lynch, MD
Richard A. Lynn, MD, FACS, RPVI Kent MacKenzie, MD Peter J. Mackrell, MD Kenneth R. Madsen, MD Derald L. Madson, Jr., MD, FACS Gregory A. Magee, MD, MSc Patrick A. Mahon, MD, FACS Jacqueline Majors, MD Michel S. Makaroun, MD Sean Malarkey, DO Mahmoud B. Malas, MD, MHS, RPVI, FACS Fatemeh Malekpour, MD Kimberly Taylor Malka, MD, PhD Lawrence I. Mallon, MD Kristyn A. Mannoia, MD M. Ashraf Mansour, MD, FACS Edward J. Marcaccio, MD Silviu C. Marica, MD Brent D. Marsden, MD William A. Marston, MD Kevin D. Martin, MD Loren Masterson, MD, MBA, FACS John H. Matsuura, MD Brian D. Matteson, MD Zachary A. Matthay, MD Mark A. Mattos, MD, DFSVS, FACS Stacey Mazzacco, MD Robert A. McCready, MD Daniel T. McDevitt, MD Ryan M. McEnaney, MD Graeme E. McFarland, MD Katharine McGinigle, MD, MPH Daniel J. McLaughlin, MD Michael M. McNally, MD George H. Meier, MD Joseph L. Mills, MD Timothy Milner, MD Samantha D. Minc, MD Erica Leith Mitchell, MD, MEd SE, FACS, DFSVS Marc E. Mitchell, MD Mark J. Mittenthal, MD Nicola Molinaro Afshin M. Molkara, MD, FACS J. Sheppard Mondy III, MD Gregory L. Moneta, MD Samuel R. Money, MD Phillip S. Moore, MD Randy D. Moore, MD
Enrique Jose Moreno Martinez, MD Edward C. Morrison, MD Nicholas J. Morrissey, MD Nicolas J. Mouawad, MD, MPH, MBA, RPVI John R. Mullins, MD Leila Mureebe, MD Sarah Murphy Scott E. Musicant, MD Firas F. Mussa, MD, MS, FACS Ryan D. Nachreiner, MD Massimo Mark Napolitano, MD Ramesh C. Narayanagowda, MD Alexander Ray Neifert, MD Peter R. Nelson, MD, MS Todd J. Neuberger, MD Tammy Tran Nguyen, MD Gary Nishanian, MD Marc A. Norris, MD Timothy J. Nypaver, MD Leigh Ann O'Banion, MD Andrea Obi, MD Christian J. Ochoa, MD Lyssa N. Ochoa, MD David J. O'Connor, MD Thomas F. O'Donnell, MD John Westley Ohman, MD Gustavo Paludetto Oliveira, MD, PhD Beth (Bales) Olson William Frank Oppat, MS, MD Nicholas H. Osborne, MD Kenneth Ouriel, MD C. Keith Ozaki, MD Frank T. Padberg, Jr., MD Heather P. Park, MD Garri Pasklinsky, MD Marc A. Passman, MD Jacek Paszkowiak, MD Donald E. Patterson, MD William H. Pearce, MD Jeffrey D. Pearce, MD Richard C. Pennell, MD Bruce Alan Perler, MD, MBA James M. Persky, MD Michael Pezold, MD, MS Robert Podolsky, MD Frank B. Pomposelli, MD Thomas L. Poulin, MD Lori C. Pounds, MD Scott Gregory Prushik, MD Khalil Qato, MD Feng Qin, MD
Reagan W. Quan, MD Jon Quatromoni, MD Elina Quiroga, MD Joseph D. Raffetto, MD Ravi Rajani, MD Bala Ramanan, MD Anantha K. Ramanathan, MBBS Daniel E. Ramirez, Jr., MD Atul S. Rao, MD Joseph H. Rapp, MD Todd E. Rasmussen, MD, FACS Pritham Reddy, MD Amy B. Reed, MD Michael A. Ricci, MD James W. Richardson, MD David A. Rigberg, MD Elena K. Rinehardt, MD Aksim Rivera, MD Andrew B. Roberts, MD James Roberts, MD, RVT, FACS William P. Robinson, MD Caron B. Rockman, MD Sean P. Roddy, MD Michael J. Rohrer, MD Elsie Ross, MD Charles B. Ross, MD Peter J. Rossi, MD Vincent L. Rowe, MD Jean Marie Ruddy, MD Todd E. Russell, MD William L. Russell, MD Patrick C. Ryan, MD Jason Thomas Ryan, MD Joseph Edward Sabat, MD, PhD Michael Joseph Sacca, MD Ulka Sachdev, MD, FACS David M. Sailors, MD Sai B. Sajja, MD, FACS, RPVI Clifford M. Sales, MD, MBA Elliot B. Sambol, MD Russell Howard Samson, MD, FACS, DFSVS, RVT Timur P. Sarac, MD Frank B. Sartor, MD Jordan Sasson, MD Salvatore T. Scali, MD Andres Schanzer, MD Marc L. Schermerhorn, MD Peter A. Schneider, MD William B. Schroder, MD FACS RVT RPVI Gregory Schultz, MD Lewis B. Schwartz, MD
Eric C. Scott, MD Gary R. Seabrook, MD Andrew J. Seiwert, MD Marcus Semel, MD Lawrence Semel, MD Piergiorgio G. Settembrini, MD, FEBVS Stephen M. Settle, MD Parth S. Shah, MD, MPH, FACS, FSVS Sherene Shalhub, MD, MPH Murray L. Shames, MD Saadat Shariff, MD Palma M. Shaw, MD Malachi G. Sheahan, III, MD Kyla Rae Shelton, MD Kevin Sheridan, MD Paula Shireman, MD Shutze Giving Fund David L. & Susan M. Dawson Charitable Fund Sammy Siada, DO Gregorio A. Sicard, MD Anton N. Sidawy, MD, MPH Aqeel Siddiqui, MD Matthew J. Sideman, MD Fernanda Costa Sampaio Silva, MD Jessica P. Simons, MD, MPH Michael J. Singh, MD Niten Singh, MD Mark Alan Sinning Jeffrey Siracuse, MD Michael J. Sise, MD Mahalingham Sivakumar, MD Christopher L. Skelly, MD Kenneth M. Slaw, PhD Matthew R. Smeds, MD Mark A. Smith, MD Robert B. Smith, III, MD Christopher J. Smolock, MD Maurice M. Solis, MD Tae K. Song, MD Michael Clarkston Soult, MD Kevin Southerland, MD Emily Spangler, MD, MS Andreas M. Spirig, MD Sunita D. Srivastava, MD John Stangel Zac Steiner, DO W. Charles Sternbergh, MD Gordon K. Stokes, MD David Stone, MD Kelli Leilani Summers, MD Adithya Suresh, MD, FACS, RPVI Martin Joseph Sylvain, MBA 13
Tiziano Tallarita, MD Houman Tamaddon, MD Tze-Woei Tan, MD Gary Tannenbaum, MD Eugene Tanquilut, DO Kevin E. Taubman, MD Angela B. Taylor Marcelo Passos Teivelis, MD, PhD Pedro G. Teixeira, MD Thomas T. Terramani, MD Theodore H. Teruya, MD Desarom Teso, MD Whitney Jordan Thorne, DO M. David Tilson III, MD Carlos H. Timaran, MD Britt H. Tonnessen, MD Fabio Andre Tornquist, Sr., MD Luis Torruella, MD, FACS, RPVI Gates Towell Margaret C. Tracci, MD JD Hoang S. Tran, MD, RVT, RPVI James F. Tretter, Jr., DO Ramesh K. Tripathi, MD, FRCS, FRACS Shirling Tsai, MD Edith Tzeng, MD Areck Ucuzian, MD, PhD Naoki Unno, MD Gilbert R. Upchurch, Jr., MD Baljeet Uppal, MD Alexander Uribe, MD Patrick S. Vaccaro, MD Jay Vasquez, MD Julio C. Vasquez, MD Mario Vasquez Hernandez, MD Dwight Vaughn Gabriela Velazquez-Ramirez, MD Chandu Vemuri, MD Paul A. Vieta Jr., MD Chiranjiv Virk, MD Uthan Vivek, MD Felix G. Vladimir, MD, FACS Robert W. Vorhies, M.D. James Wadzinski Thomas W. Wakefield, MD James Walwark, BS Xiujie Wang, MD
14
SVS F OU N DATI O N
Grace J. Wang, MD Alyson Lee Waterman, MD Fred Weaver, MD Thomas H. Webb, III, MD Michael S. Weingarten, MD Mell Burress Welborn, III, MD Brian Daniel Wernick, MD Franklin W. West, RN Scott G. Westfall, MD Paul W. White, MD Stephen C. White, MD Shari C. White Rodney A. White, MD John V. White, MD William F. Whitehead, MD Douglas B. Wilhite, MD, FACS Richard J. Wilkerson, MD Dale Wilson, MD David B. Wilson, MD Robert P. Winter, MD, RPVI, FACS Max Wohlauer, MD Edward Y. Woo, MD Dai Yamanouchi, MD, PhD Paul M. Yang, MD Eanas S. Yassa, MD Franklin Yau, MD Jeniann Yi, MD Michael Zammit, MD Connie L. Zastrow, MD Mohamed A. Zayed, MD, PhD Jack Zeltzer, MD Gregory C. Zenni, MD Wei Zhou, MD Kenneth Richard Ziegler, MD Jill Zink, MD Robert M. Zwolak, MD, PhD CLOWES DISTINGUISHED LECTURE FUND
Susan Golden Jacobson and Michael Golden Charitable Trust Jason N. MacTaggart, MD Benjamin W. Starnes, MD Gale L. Tang, MD DISASTER RELIEF FUND
Robert Rick Carter, MD Michael K. Deiparine, MD Raghu L. Motaganahalli, MD
| 2021 A N N UA L R E P O RT
Karl R. Stark, MD Austin J. Wagner, DO Jonathan Wilson, DO AWARENESS AND PREVENTION (COMMUNITY HEALTH INITIATIVES)
Olamide Alabi, MD Trissa Babrowski, MD Sateesh C. Babu, MD Frederick P. Beavers, MD, FACS The Jens Eldrup-Jorgensen Charitable Gift Fund Glenn R. Jacobowitz, MD Cali Elyse Johnson, MD, EdD Katherine Kane, MD Joseph L. Mills, MD Robert G. Molnar, MD James William Neupert Kenneth M. Slaw, PhD Shira Strauss, MD
SVS FOUNDATION
Visit Our New Website
vascular.org/svsfoundation
DONORS HAVE A MULTITUDE OF WAYS TO MAKE CONTRIBUTIONS TO THE SVS FOUNDATION.
Our supporters enable the SVS Foundation to fulfill its mission to support not only the next generation of surgeon-scientists but also education, patient awareness and disease prevention.
How toGive TO TH E
• Cash, Check, Credit Card • While paying your SVS Dues • Stocks • Donor Advised Funds • IRA Rollover (tax advantages for those 70.5 years of age and older) • Wills/Revocable Trusts • Life Insurance • Charitable Gift Annuities In addition, the SVS Foundation deeply values partnership with industry on education, research and patient awareness efforts
Please help us help our vascular families—our patients, our researchers and everyone in between. Donate now at vascular.org/GIVING.
©2020 Society for Vascular Surgery Foundation 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018-4975 Phone: 312-334-2300 / 800-258-7188